Dr Paul Eugene Wawrzynski Ii, MD | |
2602 Wilmington Rd, Suite 200, New Castle, PA 16105-1537 | |
(724) 657-3204 | |
(724) 652-7144 |
Full Name | Dr Paul Eugene Wawrzynski Ii |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 34 Years |
Location | 2602 Wilmington Rd, New Castle, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861457897 | NPI | - | NPPES |
0015838100005 | Other | PA | PROMISE NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | MD058878L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Upmc Jameson | New castle, PA | Hospital |
Butler Memorial Hospital | Butler, PA | Hospital |
Allegheny General Hospital | Pittsburgh, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Butler Medical Providers | 7416840160 | 308 |
News Archive
More than 40% of adults ages 50 to 64 years in Sweden without known heart disease were found to have some degree of atherosclerosis, according to a new study published today in the American Heart Association's flagship journal Circulation.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
More widespread use of antiretroviral drugs (ARVs) to treat HIV infection has led to drug resistance in low- and middle-income countries, but the level "is not steep enough to cause alarm, said a survey released by the World Health Organization on Wednesday," Agence France-Presse reports.
Some health care reform advocates complain that physicians rely too much on expensive technology. Published by Telescope Books, The History and Future of Medical Technology shows that today's medical technologies are worth every penny—saving lives, improving patients' quality of life, and helping doctors diagnose diseases during the earliest, most treatable stages.
› Verified 6 days ago
Entity Name | Butler Medical Providers |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619493046 PECOS PAC ID: 7416840160 Enrollment ID: O20040205000830 |
News Archive
More than 40% of adults ages 50 to 64 years in Sweden without known heart disease were found to have some degree of atherosclerosis, according to a new study published today in the American Heart Association's flagship journal Circulation.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
More widespread use of antiretroviral drugs (ARVs) to treat HIV infection has led to drug resistance in low- and middle-income countries, but the level "is not steep enough to cause alarm, said a survey released by the World Health Organization on Wednesday," Agence France-Presse reports.
Some health care reform advocates complain that physicians rely too much on expensive technology. Published by Telescope Books, The History and Future of Medical Technology shows that today's medical technologies are worth every penny—saving lives, improving patients' quality of life, and helping doctors diagnose diseases during the earliest, most treatable stages.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Paul Eugene Wawrzynski Ii, MD Po Box 1549, Butler, PA 16003-1549 Ph: (724) 284-4060 | Dr Paul Eugene Wawrzynski Ii, MD 2602 Wilmington Rd, Suite 200, New Castle, PA 16105-1537 Ph: (724) 657-3204 |
News Archive
More than 40% of adults ages 50 to 64 years in Sweden without known heart disease were found to have some degree of atherosclerosis, according to a new study published today in the American Heart Association's flagship journal Circulation.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
More widespread use of antiretroviral drugs (ARVs) to treat HIV infection has led to drug resistance in low- and middle-income countries, but the level "is not steep enough to cause alarm, said a survey released by the World Health Organization on Wednesday," Agence France-Presse reports.
Some health care reform advocates complain that physicians rely too much on expensive technology. Published by Telescope Books, The History and Future of Medical Technology shows that today's medical technologies are worth every penny—saving lives, improving patients' quality of life, and helping doctors diagnose diseases during the earliest, most treatable stages.
› Verified 6 days ago
Ankur Panchal, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1211 Wilmington Ave, Jameson Hospital, New Castle, PA 16105 Phone: 724-656-4264 | |
Dr. Silvia E Coleman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 125 Enclave Dr, New Castle, PA 16105 Phone: 724-658-6656 Fax: 724-658-6542 | |
Sheryl R Simon, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2602 Wilmington Rd, Suite 101, New Castle, PA 16105 Phone: 724-658-7300 Fax: 724-658-8414 | |
Ramesh Kaul, MD, FCCP, MS Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2602 Wilmington Rd, Suite 102, New Castle, PA 16105 Phone: 724-657-5285 Fax: 724-657-6714 | |
Dr. Sandra Milena Pinzon, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2004 W State St, New Castle, PA 16101 Phone: 724-656-4037 | |
Dr. Mohamed K Tejpar, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2602 Wilmington Rd, Suite 208, New Castle, PA 16105 Phone: 724-658-6583 Fax: 724-658-6081 | |
Dr. Kamal Wadhwa, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2602 Wilmington Rd, Suite 200, New Castle, PA 16105 Phone: 724-657-3204 Fax: 724-652-7144 |